Related Experiment Videos
Acute generalized exanthematous pustulosis after ceftriaxone use resembling sepsis
Abdurrahman Kaya1, Sibel Yıldız, Ilker Inanc Balkan
1Department of Infectious Disease, Medical School of Cerrahpasa, Istanbul University, Istanbul, Turkey. dr.abdkaya@hotmail.com
Abstract:
Acute generalized exanthematous pustulosis is an uncommon disorder, characterized by the acute onset of multiple pruritic, small, nonfollicular, sterile, superficial pustules over erythematous and edematous skin. It is frequently caused by medications, mainly antibiotics, and particularly beta-lactams. It is a rare condition that is not well known in infectious disease practice. We report a case of ceftriaxone-induced acute generalized exanthematous pustulosis that presented with the appearance of sepsis. After discontinuation of ceftriaxone, the findings were improved.
Insights
Acute generalized exanthematous pustulosis, a rare skin reaction often triggered by antibiotics like beta-lactams, can mimic sepsis. Prompt withdrawal of the causative drug, such as ceftriaxone, leads to symptom improvement.
Area of Science:
- Dermatology
- Pharmacology
- Infectious Diseases
Background:
- Acute generalized exanthematous pustulosis (AGEP) is an uncommon, severe cutaneous adverse reaction.
- It is characterized by widespread sterile pustules on erythematous skin.
- Medications, especially antibiotics like beta-lactams, are the most common triggers.
Observation:
- A case of AGEP mimicking sepsis is presented.
- The patient developed symptoms after administration of ceftriaxone, a beta-lactam antibiotic.
- The clinical presentation included multiple pruritic, superficial pustules.
Findings:
- Ceftriaxone was identified as the causative agent for AGEP.
- Discontinuation of ceftriaxone resulted in significant clinical improvement.
- The condition highlights the importance of considering drug reactions in sepsis-like presentations.
Implications:
- This case underscores the need for increased awareness of AGEP in clinical practice, particularly in infectious disease settings.
- Early recognition and drug withdrawal are crucial for managing AGEP.
- Healthcare providers should maintain a high index of suspicion for drug-induced dermatoses presenting as systemic illness.
Related Concept Videos
Staphylococcal Skin Infections
Rocky Mountain Spotted Fever
Hypersensitivity Reactions: Immune-Complex Reactions
Inhalation Anthrax
Rheumatic Heart Disease I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis